IGBA Urges Action To Ensure Sustainability
Global Off-Patent Industry Body Sets Out Recommendations
A series of global policy recommendations has been set out by the International Generic and Biosimilar Medicines Association as part of efforts to ensure a sustainable industry environment and maintain patient access to off-patent drugs.
